Stanford Diabetes / Islet Biology Work-In-Progress Seminar Series
Participants: Members of Participating Stanford Research Groups.
Meeting Time: Every Friday, 12:00-1:00 pm.
Meeting Location: Beckman 302, Developmental Biology Library.
Justin Annes MD PhD, Assistant Professor, Department of Medicine, Division of Endocrinology
Seung Kim MD PhD, Professor, Developmental Biology and (by courtesy) Medicine
Each session, held monthly, includes two speakers who provide a 20-25 minute discussion of their ongoing diabetes-related research. Presentation topics range from clinical research to basic science investigation, promoting a knowledge and collaboration between these spheres. The presentation format encourages questions and discussion both during and after each presentation. Presentations primarily focus on un-published work and as these meetings are intended to build new collaborations, share new insights (particularly new technologic innovations and how they might be applied) and facilitate new ideas/ research directions. Presenters and attendees include everyone from professors to undergraduate students. Thus this venue also aligns with our center’s training mission. Typical attendance is ~30-40 individuals per session. Snacks and drinks are provided to facilitate informal socializing and discussion following the presentations.
Zahra Bahrami-Nejad (Teruel lab) - A core component of mature adipocytes enforces cell identity by mediating adipocyte differentiation
Dr. Terry Unterman - Regulatory Networks in Diabetes: Integrated Regulation of Hepatic Glucose and Lipid Metabolism by FoxO Proteins
February 9th: Jason Tsai (Bertozzi lab): Sensitive and multiplex quantification of anti-Islet cell antibodies for Type 1 Diabetes diagnostics and risk assessments
Dr. Anisha Patel: Examining Policies to Promote Access to Free Water in Schools as an Alternative to Sugar Sweetened Beverages
February 2nd: Monte Winslow: Genome Engineering in the Mouse Pancreas/Marina Basina: Managing Type 2 Diabetes: Where are we in 2018?
January 26th: Dr. Everett Meyer (Defining disease associated invariant NKT in human type 1 diabetes)/Dr. Paul Bollyky (IL-2 delivery and immune modulation in type 1 diabetes)
January 12th: Tom Soh (Technology for continuously measuring specific biomolecules in vivo)/Korey Hood (Science of Behavior: Opportunities to Optimize Diabetes Outcomes)
January 10, 2018: Invited guest speaker - Danny Chou, PhD Assistant Professor-University of Utah "Toward Optimal Insulin Action and Performance for People with Diabetes"
December 1st: Heshan Peiris (Kim lab - Conditional Genetics and Human Islet Studies to Discover Diabetes Risk Gene Function)/Krissie Tellez (Kim lab - Elucidating in Vivo Mechanisms Regulating Glucagon Secretion in a Glucagon Null Mouse)
November 3rd: Tim Horton (Annes lab -Zinc chelators as beta-cell selective agents)/Kent Jensen (introduction to SIRC and DIMC cores)
October 6th: Knowles Lab (Heritable Diabetes and Metabolic Risk)/ Snyder Lab (Diabetes Omics)
September 1: Kay Lab (Islet Targeting)/ Meyer Lab (Immune cell targeting of the Islet)
July 7: Bollyky Lab (Type I diabetes Protection)/ McLaughlin Lab (CD44 and T2D)
June 2: Feldman Lab
Brian J. Feldman (Feldman lab): "Hypertrophy or hyperplasia: post-prandial contemplations."
Avnesh S. Thakor (Thakor Lab): "Delivery of therapeutics directly to the pancreas."
May 5th, 2017
Heshan Peiris (Seung Kim Lab): BCL11A: A T2D Risk Gene From GWAS That Regulates Human Beta Cell Function
Hannah Moeller (Justin Annes Lab): Discovering mechanisms for promoting the beta cell identity
April 26th 2017, 9AM-5PM
Frontiers in Diabetes Research at Stanford
December 9th, 2016
Marco Mignardi (Quake Lab) : In situ gene expression profiling of pancreatic tissues
Yan Hang (Kim Lab): A mammalian decretin hormone that regulates islet insulin output during nutrient restriction
November 28th, 2016: Stanford Diabetes Research Forum (celebrating Diabetes Awareness Month):
Speakers: Drs. Vivek Bhalla, Eric Gross, Joyce Liao, Elena Matsa, Tracey McLaughlin, Nadine Nagy, Seung Kim and Chelsea Kliebert (Jennifer Cochran lab) and Zahra Bahrami (Mary Teruel lab)
October meeting: cancelled
September 9th, 2016:
Everett Meyer: Blockade of signaling hub repulsive guidance molecule B (RGMb) delays islet allograft rejection
Sun Kim: Insulin Clearance: an underappreciated modulator of plasma insulin
July 8th, 2016:
Vivek Sunkari (Bollyky Lab): Targeting Hyaluronan to Treat Type 2 Diabetes
Justin Annes: Genetic Disruption of Adenosine Kinase in Mouse Pancreatic β-Cells Protects Against High Fat Diet-Induced Glucose Intolerance
June 6th, 2016:
Seung Kim and Sangbin Park: Drosophila and diabetes: tapping the deep evolutionary roots of islet biology
Linda Yip (Fathman Lab): Using gene expression of PBCs to identify risk and progression of T1D
May 20th, 2016:
Brian Hsueh (Deisseroth Lab): Quantitative tools for evaluating 3D structure in the pancreas
Everett Meyer Lab: Using chimeric antigen receptor T-regulatory cells to induce tolerance and deliver directed signals to pancreatic islet allografts
April 13th, 2016:
Wenyu Zhou (Snyder group): Profiling bacterial community changes in diet-induced weight gain/loss
Li-Fen Liu (McLaughlin group): Adipose tissue macrophages impair preadipocyte differentiation in humans
March 11th, 2016:
Nadine Nagy (Bollyky Lab) Immune tolerance and hyaluronan
Martin Enge (Quake Lab) Single cell transcriptional analysis from young and old human beta-cells.
February 16th, 2016:
Seung Kim: Diabetes-Related Resources at Stanford
Justin Annes: Identification of Novel β-Cell replication-promoting Small Molecules